Welcome to our dedicated page for AUNA S.A. news (Ticker: AUNA), a resource for investors and traders seeking the latest updates and insights on AUNA S.A. stock.
Auna S.A. reports developments for a Latin American healthcare platform operating in Mexico, Peru and Colombia. The company combines a network of hospitals, ambulatory centers, prevention and wellness facilities with oncology and selected general health plans, with segment reporting around Oncosalud Peru and healthcare services in Peru, Colombia and Mexico.
Recurring news covers quarterly financial results, key performance indicators, operating trends by country, capital structure actions, debt refinancing, public-private partnership activity such as Torre Trecca in Lima, and strategic healthcare collaborations. Updates also include Form 20-F reporting dates and financial guidance tied to its integrated services-and-plans model.
Auna (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru, and Colombia, announced that its controlling shareholder Enfoca has successfully refinanced its sponsor-level financing. The new facility extends the maturity date from October 5, 2025, to the end of June 2027, and includes improved economic terms for sponsors and pre-IPO shareholders.
Importantly, Auna is not a party to, does not guarantee, and has no liability regarding the debt under this new sponsor-level financing. The refinancing is expected to strengthen the long-term alignment between Auna and its pre-IPO shareholders while supporting the company's strategic growth initiatives in Spanish-speaking Latin America.
Auna (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its First Quarter 2025 financial results announcement. The company will release its earnings after market close on Tuesday, May 20, 2025, followed by a conference call on Wednesday, May 21, 2025 at 8:00 a.m. ET.
A quiet period will be observed from Monday, April 28 through Tuesday, May 20, 2025. Interested parties can participate in the conference call via telephone using the toll-free number +1 888 596 4144 or international number +1 646 968 2525 with entry passcode 3884034.
Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024. The report was filed with the Securities and Exchange Commission (SEC) on April 10, 2025.
The Annual Report can be accessed through the SEC's website or the 'Financial Info' section of Auna's Investor Relations website. Shareholders can also request a free hard copy of the company's audited financial statements or complete 2024 Form 20-F by contacting the Investor Relations team.
Auna (NYSE: AUNA), a Latin American healthcare platform, reported strong financial results for Q4 and FY 2024. Fourth quarter highlights include:
- Revenue up 4% YoY to S/1,063 million (+11% FXN)
- Adjusted EBITDA increased 19% YoY to S/254 million (+28% FXN)
- Adjusted EBITDA margin expanded 3.1 p.p. to 23.9%
- Net Income improved to S/24 million from a loss of S/219 million in 4Q23
Full-year 2024 performance showed:
- Revenue growth of 13% YoY to S/4,386 million
- Adjusted EBITDA rose 20% YoY to S/993 million
- Net Income of S/124 million, compared to a loss of S/214 million in 2023
- Leverage ratio improved to 3.6x from 4.5x in 4Q23
The company faced challenges in Colombia with certain payors but showed strong momentum in Mexico and Peru. Auna maintains its internal guideline of 20% FXN Adjusted EBITDA growth annually, though 2025 performance will depend on Colombian operations.
Auna S.A. (NYSE: AUNA) has signed an exclusive five-year agreement with Opción Oncología, Monterrey's premier oncology ambulatory clinic. The partnership brings eight distinguished physicians (six oncologists and two radiation oncologists) to Auna's network, who currently manage approximately 30% of private oncology treatments in Monterrey.
The medical team will relocate to Doctors Hospital, integrating 100% of their treatments within Auna's network over time. Notable additions include Dr. César González de León, appointed as Chair of Medical Oncology, and Dr. Cuauhtémoc De la Peña Hinojosa, who will serve as Chair of Radiation Oncology on Auna Mexico's Oncology Board.
This strategic move follows the launch of OncoMexico and precedes the inauguration of Auna's Oncology Research Center in Mexico, which will collaborate with existing research centers in Peru and Colombia.
Auna (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its Fourth Quarter and Full-Year 2024 financial results announcement. The earnings release will be published on Monday, March 10, 2025, after market close. A conference call will follow on Tuesday, March 11, 2025, at 8:00 a.m. ET. The company has established a quiet period from February 17 through March 10, 2025. Interested parties can participate via phone using the toll-free number +1 888 596 4144 or international number +1 646 968 2525 with entry passcode 3884034, or join through the webcast.
Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the completion of a private placement of USD 57.8 million in 10.000% Senior Secured Notes due 2029. The proceeds were used to fully redeem its existing 6.500% Senior Secured Notes due 2025, at a redemption price of 101.625% plus interest. These Additional 2029 Notes were issued under the same indenture as the company's outstanding USD 253 million 10.000% Senior Secured Notes from December 2023, bringing the total outstanding amount to USD 310.8 million.